Zhang Jingqian, Mu Shidai, Cai Li, Ai Lisha, Wu Yaohui
Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Key Lab of Molecular Biological Targeted Therapies of the Ministry of Education, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Front Oncol. 2024 May 1;14:1364266. doi: 10.3389/fonc.2024.1364266. eCollection 2024.
Osteolytic lesions are infrequently observed in adult patients with acute myeloid leukemia (AML). This report details the case of a 66-year-old male patient who presented with myeloid sarcoma (MS), osteolytic lesion and pancytopenia. Effective treatments were delayed due to diagnostic challenges and the rapid progression of the disease. It is essential to consider AML in the differential diagnosis when faced with a patient presenting osteolytic lesions and pancytopenia.
溶骨性病变在成年急性髓系白血病(AML)患者中并不常见。本报告详细介绍了一名66岁男性患者的病例,该患者表现为髓系肉瘤(MS)、溶骨性病变和全血细胞减少。由于诊断困难和疾病快速进展,有效的治疗被延误。当面对出现溶骨性病变和全血细胞减少的患者时,在鉴别诊断中考虑AML至关重要。